Detalhe da pesquisa
1.
Olaratumab in the management of advanced soft tissue sarcoma.
J Oncol Pharm Pract;
25(2): 442-448, 2019 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30032714
2.
Avelumab: A Review of Its Application in Metastatic Merkel Cell Carcinoma.
Ann Pharmacother;
52(9): 928-935, 2018 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29616562
3.
Successful treatment of arthritis induced by checkpoint inhibitors with tocilizumab: a case series.
Ann Rheum Dis;
76(12): 2061-2064, 2017 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28830882
4.
An Unusual Case of Central Retinal Vein Occlusion and Review of the Toxicity Profile of Regorafenib in GIST Patients.
Curr Oncol Rep;
18(8): 49, 2016 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27319943
5.
Controversies in the management of advanced melanoma: "gray" areas amid the "black and blue".
Ann Pharmacother;
48(11): 1456-68, 2014 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25056920
6.
Dabrafenib therapy for advanced melanoma.
Ann Pharmacother;
48(4): 519-29, 2014 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24259661
7.
Ipilimumab for advanced melanoma: a pharmacologic perspective.
J Oncol Pharm Pract;
19(3): 195-201, 2013 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23047236
8.
The influence of family socioeconomic status on toothbrushing practices in Australian children.
J Public Health Dent;
81(4): 308-315, 2021 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34622451
9.
Factors patients consider when accessing oral health care.
Aust J Prim Health;
27(6): 503-508, 2021 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34809747
10.
Guillain-Barre syndrome observed with adoptive transfer of lymphocytes genetically engineered with an NY-ESO-1 reactive T-cell receptor.
J Immunother Cancer;
7(1): 296, 2019 11 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31703609
11.
Immune checkpoint inhibitor related myasthenia gravis: single center experience and systematic review of the literature.
J Immunother Cancer;
7(1): 319, 2019 11 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31753014
12.
Corrections to: Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature.
J Immunother Cancer;
7(1): 158, 2019 Jun 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31234936
13.
Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature.
J Immunother Cancer;
7(1): 106, 2019 04 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30992053
14.
Anti-programmed cell death-1 (PD-1) monoclonal antibodies in treating advanced melanoma -- a clinical update.
Discov Med;
25(135): 31-40, 2018 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29466692
15.
Endoscopic and Histologic Features of Immune Checkpoint Inhibitor-Related Colitis.
Inflamm Bowel Dis;
24(8): 1695-1705, 2018 07 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29718308
16.
The efficacy and safety of adjuvant interferon-alfa therapy in the evolving treatment landscape for resected high-risk melanoma.
Expert Opin Drug Saf;
16(8): 933-940, 2017 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28627943
17.
Treatment patterns, efficacy and toxicity of regorafenib in gastrointestinal stromal tumour patients.
Sci Rep;
7(1): 9519, 2017 08 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28842575
18.
Anti-programmed cell death-1 (PD-1) monoclonal antibodies in treating advanced melanoma.
Discov Med;
19(106): 393-401, 2015 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26105702
19.
Managing Side Effects of Vemurafenib Therapy for Advanced Melanoma.
J Adv Pract Oncol;
5(6): 400-10, 2014.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26328215
20.
Treatment of BRAF-mutated advanced cutaneous melanoma.
Chin Clin Oncol;
3(3): 28, 2014 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25841454